Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

NCT: NCT04427384 · RECRUITING

NCT IDNCT04427384
StatusRECRUITING
Start Date2020-09-11
Completion2028-12-31
SponsorGT Medical Technologies, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑